Biogenesis

Palo Alto, United States

Biogenesis is building the end-to-end platform for clinical research.

$2.5M raised

Mar 2024

Seed

Top Investors

Kleiner PerkinsAlt CapitalGreylockPareto HoldingsCory Levy

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biogenesis raised?

Biogenesis has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in March 2024.

Who are Biogenesis's investors?

Biogenesis's investors include Kleiner Perkins, Alt Capital, Greylock, Pareto Holdings, Cory Levy.

Where is Biogenesis headquartered?

Biogenesis is headquartered in Palo Alto, United States.

What does Biogenesis do?

Biogenesis is building the end-to-end platform for clinical research.

What stage is Biogenesis at?

Biogenesis is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2024.

MLA

"Biogenesis — Funding & Investors." VCBacked, March 1, 2024, https://www.vcbacked.co/company/biogenesis. Accessed June 4, 2026.

APA

VCBacked. (2024). Biogenesis — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/biogenesis

Wikipedia (cite web)

{{cite web |title=Biogenesis — Funding & Investors |url=https://www.vcbacked.co/company/biogenesis |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2024.